Products
Solutions
Resources
Pricing
Security
Products
IP
Patent Search & Analysis
Novelty Search
FTO Search
Design FTO Search
Patent Drafting & OAR
SEP Assessment
Engineering
Tech Research & Engineering Solutions
Find Solutions with TRIZ
Life Sciences
Drug Discovery & Research
SAR Data Extraction
Lead Compound
Materials R&D
Materials Research & Development
MCP Servers
REST APIs
Skill Hub
UI Widgets
Desktop
Beta
Solutions
Featured Use Cases
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Resources
Featured Guides
Patentability Search vs. FTO
Find Prior Art
Review FTO Evidence
Discover
Free AI Tools
Benchmark Reports
Blog & Insights
Support
Help Center
Community & Socials
LinkedIn
X
YouTube
Substack
Pricing
Security
Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
2
results about How to "Reduce endotoxin" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A reusable plasmid large-scale purification filler and a preparation method thereof
Pending
CN122399750A
Improve adsorption capacity
increase the area
Silicon dioxide
Biology
本发明提供一种可重复使用的质粒大提纯化填料及其制备方法,所述介质以无定型二氧化硅为基质,在所述二氧化硅的表面通过配基功能化修饰得到的;其中,所述功能化修饰采用的活化剂为氨基化硅化偶联剂。本发明提供的可重复使用的质粒大提纯化填料在实际质粒大提提取过程中表现出高提取量、无rRNA残留、内毒素低等优异特性,而且具有操作简单、工艺可控、高提取量、高纯度、低内毒素等优点。
View all
Owner:
XINGYAO BIOTECHNOLOGY (SUZHOU) CO LTD
Drug carrier based on N-acetylglucosamine, drug preparation and preparation method
Pending
CN121818943A
Quick point release
Reduce endotoxin
Pharmaceutical non-active ingredients
Granular delivery
Drug release rate
Ketone
The invention provides a
drug
carrier based on N-
acetylglucosamine
, a
drug
preparation and a preparation method. The
drug
carrier based on N-
acetylglucosamine
comprises N-
acetylglucosamine
and a cross-linking agent, the cross-linking agent is a compound with an
aldehyde
group or a
ketone
group, and the
aldehyde
group or the
ketone
group reacts with the deacetylated N-acetylglucosamine to generate one or more of a
hydrazide
bond, a
hydrazone
bond or an
imine
bond. The
drug carrier
based on N-acetylglucosamine shows remarkable advantages in the aspects of
particle size distribution
, drug loading capacity, encapsulation efficiency and cumulative
drug release
rate.
View all
Owner:
QINHUANGDAO BOHAI RIM BIOLOGICAL IND RES INST BEIJING UNIV OF CHEM TECH
+1
Login to View More